601 related articles for article (PubMed ID: 27550371)
21. Adjunctive cariprazine as a novel effective strategy for treating major depressive disorder: A systematic review and meta-analysis.
Xie M; Qiu Y; Wang M; Wei X; Tao Y; Duan A; Shang J; Gao W; Wang Z
J Psychiatr Res; 2024 Apr; 172():71-80. PubMed ID: 38367320
[TBL] [Abstract][Full Text] [Related]
22. The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders.
De Berardis D; Orsolini L; Iasevoli F; Prinzivalli E; de Bartolomeis A; Serroni N; Mazza M; Valchera A; Fornaro M; Vecchiotti R; Carano A; Sepede G; Vellante F; Matarazzo I; Pompili M; Perna G; Conti C; Segura-García C; Martinotti G; Di Giannantonio M
Curr Pharm Des; 2016; 22(33):5144-5162. PubMed ID: 27396597
[TBL] [Abstract][Full Text] [Related]
23. Cariprazine in the treatment of Bipolar Disorder: A systematic review and meta-analysis.
Pinto JV; Saraf G; Vigo D; Keramatian K; Chakrabarty T; Yatham LN
Bipolar Disord; 2020 Jun; 22(4):360-371. PubMed ID: 31618503
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.
Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
Schizophr Res; 2014 Feb; 152(2-3):450-7. PubMed ID: 24412468
[TBL] [Abstract][Full Text] [Related]
25. Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Ali E; Latif F; Mashkoor Y; Sheikh A; Iqbal A; Owais R; Ahmed J; Naveed S; Moeed A; Ullah I; Mughal S
Asian J Psychiatr; 2024 May; 95():104005. PubMed ID: 38513509
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial.
Yatham LN; Vieta E; Earley W
Int Clin Psychopharmacol; 2020 May; 35(3):147-156. PubMed ID: 32058426
[TBL] [Abstract][Full Text] [Related]
27. Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapy.
Citrome L
Adv Ther; 2013 Feb; 30(2):114-26. PubMed ID: 23361833
[TBL] [Abstract][Full Text] [Related]
28. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
Earley W; Burgess MV; Rekeda L; Dickinson R; Szatmári B; Németh G; McIntyre RS; Sachs GS; Yatham LN
Am J Psychiatry; 2019 Jun; 176(6):439-448. PubMed ID: 30845817
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
Durgam S; Earley W; Guo H; Li D; Németh G; Laszlovszky I; Fava M; Montgomery SA
J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
[TBL] [Abstract][Full Text] [Related]
30. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
[TBL] [Abstract][Full Text] [Related]
31. Use of cariprazine in psychiatric disorders: A systematic review.
Chhatlani A; Farheen SA; Setty MJ; Tampi RR
Ann Clin Psychiatry; 2018 Nov; 30(4):326-334. PubMed ID: 30372510
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.
Kane JM; Zukin S; Wang Y; Lu K; Ruth A; Nagy K; Laszlovszky I; Durgam S
J Clin Psychopharmacol; 2015 Aug; 35(4):367-73. PubMed ID: 26075487
[TBL] [Abstract][Full Text] [Related]
33. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
Durgam S; Earley W; Li R; Li D; Lu K; Laszlovszky I; Fleischhacker WW; Nasrallah HA
Schizophr Res; 2016 Oct; 176(2-3):264-271. PubMed ID: 27427558
[TBL] [Abstract][Full Text] [Related]
34. A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression.
Earley WR; Burgess M; Rekeda L; Hankinson A; McIntyre RS; Suppes T; Calabrese JR; Yatham LN
J Affect Disord; 2020 Feb; 263():386-395. PubMed ID: 31969269
[TBL] [Abstract][Full Text] [Related]
35. Cariprazine: First Global Approval.
McCormack PL
Drugs; 2015 Nov; 75(17):2035-43. PubMed ID: 26510944
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
[TBL] [Abstract][Full Text] [Related]
37. Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability.
Citrome L
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):193-206. PubMed ID: 23320989
[TBL] [Abstract][Full Text] [Related]
38. Cariprazine and akathisia, restlessness, and extrapyramidal symptoms in patients with bipolar depression.
Citrome L; Yatham LN; Patel MD; Barabássy Á; Hankinson A; Earley WR
J Affect Disord; 2021 Jun; 288():191-198. PubMed ID: 33915374
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.
Marder S; Fleischhacker WW; Earley W; Lu K; Zhong Y; Németh G; Laszlovszky I; Szalai E; Durgam S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):127-136. PubMed ID: 30470662
[TBL] [Abstract][Full Text] [Related]
40. Cariprazine in Bipolar Depression and Mania: State of the Art.
Mazza M; Marano G; Traversi G; Carocci V; Romano B; Janiri L
CNS Neurol Disord Drug Targets; 2018; 17(10):723-727. PubMed ID: 30152291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
